A detailed history of Psagot Value Holdings Ltd. transactions in Pfizer Inc stock. As of the latest transaction made, Psagot Value Holdings Ltd. holds 5,022 shares of PFE stock, worth $140,515. This represents 1.26% of its overall portfolio holdings.

Number of Shares
5,022
Previous 44,172 88.63%
Holding current value
$140,515
Previous $1.27 Million 89.07%
% of portfolio
1.26%
Previous 0.55%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$25.89 - $29.73 $1.01 Million - $1.16 Million
-39,150 Reduced 88.63%
5,022 $139,000
Q4 2023

Feb 08, 2024

SELL
$26.13 - $33.94 $30,702 - $39,879
-1,175 Reduced 2.59%
44,172 $1.27 Million
Q3 2023

Oct 30, 2023

BUY
$32.09 - $37.51 $705,980 - $825,220
22,000 Added 94.23%
45,347 $1.46 Million
Q2 2023

Aug 03, 2023

SELL
$36.12 - $41.79 $677,358 - $783,687
-18,753 Reduced 44.54%
23,347 $847,000
Q1 2023

Jun 20, 2023

SELL
$39.39 - $51.28 $2.32 Million - $3.02 Million
-58,885 Reduced 58.31%
42,100 $1.69 Million
Q4 2022

Jan 30, 2023

BUY
$41.75 - $54.5 $30,519 - $39,839
731 Added 0.73%
100,985 $5.17 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $1.61 Million - $1.96 Million
-36,763 Reduced 26.83%
100,254 $4.39 Million
Q2 2022

Aug 09, 2022

SELL
$46.53 - $55.17 $453,853 - $538,128
-9,754 Reduced 6.65%
137,017 $7.18 Million
Q1 2022

May 16, 2022

BUY
$45.75 - $56.69 $2.68 Million - $3.32 Million
58,574 Added 66.41%
146,771 $7.6 Million
Q4 2021

Mar 14, 2022

BUY
$41.32 - $61.25 $2.41 Million - $3.57 Million
58,272 Added 194.73%
88,197 $1.29 Million
Q3 2021

Mar 07, 2022

BUY
$39.25 - $50.42 $1.17 Million - $1.51 Million
29,925 New
29,925 $1.29 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Psagot Value Holdings Ltd. Portfolio

Follow Psagot Value Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Psagot Value Holdings Ltd. , based on Form 13F filings with the SEC.

News

Stay updated on Psagot Value Holdings Ltd. with notifications on news.